SARAH JAMES: Open Payments
NPI 1831347913 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 25 payments from 7 companies in 2025. Trend: 2023 $578 · 2024 $680 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $149 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $59 |
| BridgeBio Pharma, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: Kerendia, LEQVIO, JARDIANCE, WAINUA, LOKELMA, FARXIGA, Attruby, CAMZYOS.
Industry payments across NY — which companies pay providers there.
